S. 1435 (119th)Bill Overview

Accountability in Foreign Animal Research Act

Health|Health
Cosponsors
Support
Republican
Introduced
Apr 10, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

Prohibits the Department of Health and Human Services from conducting or funding biomedical research that tests on vertebrate animals in facilities located in, or owned or controlled by, specified foreign countries (China including Hong Kong, Iran, North Korea, and Russia) or any other country the Secretary designates in consultation with State and Defense. Bars HHS support via grants, contracts, or other funding vehicles for such foreign-based animal testing.

Why people may split

Security vs. scientific collaboration: national-security focus clashes with global research needs

Watch point

Relative to its intended legislative type, this bill establishes a targeted prohibition on HHS-funded animal experimentation tied to specified foreign countries and a consultative reporting process for adding others.

Prohibits the Department of Health and Human Services from conducting or funding biomedical research that tests on vertebrate animals in facilities located in, or owned or controlled by, specified foreign countries (China including Hong Kong, Iran, North Korea, and Russia) or any other country the Secretary designates in consultation with State and Defense.

Bars HHS support via grants, contracts, or other funding vehicles for such foreign-based animal testing.

Requires HHS to report to specific congressional committees within 60 days whenever it designates an additional country, explaining the reasoning.

Passage40/100

Narrow, security-framed restriction increases viability, but research community concerns and higher-chamber consensus requirements reduce overall odds.

CredibilityPartially aligned

Relative to its intended legislative type, this bill establishes a targeted prohibition on HHS-funded animal experimentation tied to specified foreign countries and a consultative reporting process for adding others. It names the implementing officer and the committees to receive reports, but omits several implementation details commonly expected for a funding restriction.

Contention60/100

Security vs. scientific collaboration: national-security focus clashes with global research needs

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
WorkersWorkers

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • WorkersStops taxpayer dollars from directly supporting animal experimentation in specified adversarial-country laboratories.
  • WorkersReduces risks of inadvertent transfer of technologies or biological materials through animal testing collaborations.
  • Potential benefitReinforces national security by restricting research ties with countries identified as concerns.
Likely burdened
  • WorkersLimits international scientific collaboration, which could slow some biomedical research advances.
  • Potential burdenComplicates multinational studies using vertebrate models, potentially delaying projects or excluding partners.
  • Potential burdenImposes administrative screening burdens on HHS and grant recipients to ensure compliance.
03 · Why people split

Why the argument around this bill splits.

Security vs. scientific collaboration: national-security focus clashes with global research needs
Progressive55%

Generally supportive of preventing taxpayer dollars from aiding adversarial regimes, but wary of collateral harm to global public-health science and animal welfare oversight.

Concerned about impacts on pandemic research, multinational collaborations, and transparency in how designations are made.

Might press for narrow, public-health-preserving exceptions and strong oversight.

Split reaction
Centrist50%

Sees the bill as a reasonable national-security precaution but notes vagueness and potential administrative burden.

Wants clearer definitions, targeted scope, and safeguards to avoid unintended disruption of legitimate research and emergency cooperation.

Likely to weigh benefits against practical implementation costs.

Split reaction
Conservative85%

Likely strongly supportive as a national-security and accountability measure to prevent U.S. taxpayer funds from benefiting adversarial regimes.

May argue for expanding scope and enforcement and favor no broad exemptions.

Views reporting requirements as a minimal oversight step.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Narrow, security-framed restriction increases viability, but research community concerns and higher-chamber consensus requirements reduce overall odds.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No formal cost estimate or agency compliance analysis included
  • Vague definition and scope of "owned or controlled" foreign facilities
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Security vs. scientific collaboration: national-security focus clashes with global research needs

Narrow, security-framed restriction increases viability, but research community concerns and higher-chamber consensus requirements reduce o…

Unlocked analysis

Relative to its intended legislative type, this bill establishes a targeted prohibition on HHS-funded animal experimentation tied to specified foreign countries and a consultative reporting process for adding others. It…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis